Larissa Satiko Alcantara Sekimoto Matsuyama, Victoria Harle, Victoria Offord, Alastair Droop, Roy Rabbie, Manik Garg, Martha Estefania Vázquez-Cruz, Carla Daniela Robles-Espinoza, Gemma Turner, David Fraser, Erica Aparecida de Oliveira, Danielle Goncalves de Carvalho, Natasha Andressa Nogueira Jorge, Mariana Boroni, Patricia A Possik, David J Adams, Silvya Stuchi Maria-Engler
{"title":"敲除SIN3B可调节皮肤黑色素瘤的转录程序和细胞存活。","authors":"Larissa Satiko Alcantara Sekimoto Matsuyama, Victoria Harle, Victoria Offord, Alastair Droop, Roy Rabbie, Manik Garg, Martha Estefania Vázquez-Cruz, Carla Daniela Robles-Espinoza, Gemma Turner, David Fraser, Erica Aparecida de Oliveira, Danielle Goncalves de Carvalho, Natasha Andressa Nogueira Jorge, Mariana Boroni, Patricia A Possik, David J Adams, Silvya Stuchi Maria-Engler","doi":"10.1016/j.phrs.2025.107785","DOIUrl":null,"url":null,"abstract":"<p><p>SIN3 is a critical component of the histone deacetylase complex. Utilizing whole transcriptome data from melanoma patient samples we reveal that elevated levels of SIN3B are associated with poor survival outcomes with in vitro studies showing increased SIN3B expression in BRAF-mutant metastatic melanoma cell lines. The generation of isogenic SIN3B knockout cell lines indicated that SIN3B disruption led to a decrease in pathways associated with tumor invasion, migration, and cell-cell interactions. Moreover, pooled genome-wide CRISPR/Cas9 screens highlighted POLE4 and STK11 as crucial for the fitness and survival of SIN3B-knockout melanoma cells suggesting a role for these genes in epistasis with SIN3B. In summary, our findings suggest that SIN3B plays a pivotal role in modulating the behavior of melanoma cells, with implications for tumor growth and response to therapy.</p>","PeriodicalId":19918,"journal":{"name":"Pharmacological research","volume":" ","pages":"107785"},"PeriodicalIF":9.1000,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Knockout of SIN3B modulates transcriptional programs and cell survival in cutaneous melanoma.\",\"authors\":\"Larissa Satiko Alcantara Sekimoto Matsuyama, Victoria Harle, Victoria Offord, Alastair Droop, Roy Rabbie, Manik Garg, Martha Estefania Vázquez-Cruz, Carla Daniela Robles-Espinoza, Gemma Turner, David Fraser, Erica Aparecida de Oliveira, Danielle Goncalves de Carvalho, Natasha Andressa Nogueira Jorge, Mariana Boroni, Patricia A Possik, David J Adams, Silvya Stuchi Maria-Engler\",\"doi\":\"10.1016/j.phrs.2025.107785\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>SIN3 is a critical component of the histone deacetylase complex. Utilizing whole transcriptome data from melanoma patient samples we reveal that elevated levels of SIN3B are associated with poor survival outcomes with in vitro studies showing increased SIN3B expression in BRAF-mutant metastatic melanoma cell lines. The generation of isogenic SIN3B knockout cell lines indicated that SIN3B disruption led to a decrease in pathways associated with tumor invasion, migration, and cell-cell interactions. Moreover, pooled genome-wide CRISPR/Cas9 screens highlighted POLE4 and STK11 as crucial for the fitness and survival of SIN3B-knockout melanoma cells suggesting a role for these genes in epistasis with SIN3B. In summary, our findings suggest that SIN3B plays a pivotal role in modulating the behavior of melanoma cells, with implications for tumor growth and response to therapy.</p>\",\"PeriodicalId\":19918,\"journal\":{\"name\":\"Pharmacological research\",\"volume\":\" \",\"pages\":\"107785\"},\"PeriodicalIF\":9.1000,\"publicationDate\":\"2025-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacological research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.phrs.2025.107785\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.phrs.2025.107785","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Knockout of SIN3B modulates transcriptional programs and cell survival in cutaneous melanoma.
SIN3 is a critical component of the histone deacetylase complex. Utilizing whole transcriptome data from melanoma patient samples we reveal that elevated levels of SIN3B are associated with poor survival outcomes with in vitro studies showing increased SIN3B expression in BRAF-mutant metastatic melanoma cell lines. The generation of isogenic SIN3B knockout cell lines indicated that SIN3B disruption led to a decrease in pathways associated with tumor invasion, migration, and cell-cell interactions. Moreover, pooled genome-wide CRISPR/Cas9 screens highlighted POLE4 and STK11 as crucial for the fitness and survival of SIN3B-knockout melanoma cells suggesting a role for these genes in epistasis with SIN3B. In summary, our findings suggest that SIN3B plays a pivotal role in modulating the behavior of melanoma cells, with implications for tumor growth and response to therapy.
期刊介绍:
Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. Pharmacological research publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.